Presentation is loading. Please wait.

Presentation is loading. Please wait.

Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H

Similar presentations


Presentation on theme: "Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H"— Presentation transcript:

1 Outcomes of endovascular interventions for salvage of renal transplant allografts 
Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H. Osborne, MD, MS, Michael Englesbe, MD, Eva Rzucidlo, MD, Peter K. Henke, MD, John E. Rectenwald, MD, MS, Katherine A. Gallagher, MD  Journal of Vascular Surgery  Volume 57, Issue 6, Pages (June 2013) DOI: /j.jvs Copyright © 2013 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Algorithm for assessment of declining transplant allograft function. ACE-I, Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CT, computed tomography; HTN, hypertension; MRI, magnetic resonance imaging. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Renal transplant allograft survival by primary indication of endovascular intervention: worsening renal function (renalFxn), renovascular hypertension (HTN), or structural anomalies. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Renal transplant allograft survival by presence of renovascular hypertension (HTN) at the time of the initial endovascular intervention. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions


Download ppt "Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H"

Similar presentations


Ads by Google